Global patterns of methamphetamine use

Current Opinion in Psychiatry

Volumn 28, Issue 4, 2015, Pages 269-274

  Chomchai, Chulathida ^a   Chomchai, Summon ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Amphetamine; Amphetamine type stimulants; Drug of abuse; ICE; Methamphetamine

Indexed keywords

METHAMPHETAMINE; CENTRAL STIMULANT AGENT;

DRUG ABUSE; DRUG BIOAVAILABILITY; DRUG PURITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAXIMUM PLASMA CONCENTRATION; MEN WHO HAVE SEX WITH MEN; PLASMA HALF LIFE; PREGNANCY; REVIEW; RISK; SEXUAL HEALTH; VOLUME OF DISTRIBUTION; ADOLESCENT; ADOLESCENT BEHAVIOR; ADULT; DRUG TRAFFIC; FEMALE; HEALTH; HIGH RISK BEHAVIOR; HIV INFECTIONS; MALE; SEX WORKER; SEXUALLY TRANSMITTED DISEASES; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; SYPHILIS; TRANSMISSION; UNSAFE SEX;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG TRAFFICKING; FEMALE; GLOBAL HEALTH; HIV INFECTIONS; HUMANS; MALE; METHAMPHETAMINE; RISK; RISK-TAKING; SEX WORKERS; SEXUALLY TRANSMITTED DISEASES; SUBSTANCE-RELATED DISORDERS; SYPHILIS; UNSAFE SEX;

EID: 84942593462     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0000000000000168     Document Type: Review

References (58)

1. Vearrier D, Greenberg MI, Miller SN, et al. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. Dis Mon 2012; 38.
2. Courtney KE, Ray LA. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug Alcohol Depend 2014; 143c:11-21.
3. UNODC. World Drug Report 2013. 2013.
4. Chung H, Park M, Hahn E, et al. Recent trends of drug abuse and drugassociated deaths in Korea. Ann N Y Acad Sci 2004; 1025:458-464.
5. UNODC. World Drug Report 2014. 2014. http://www.unodc.org/southasia//frontpage/2014/Jan/india-first-ever-study-looks-at-trends-in-amphetamine-typestimulants- use.html. [Accessed on December 23, 2014].
6. Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2014; 382:1575-1586.
7. Barati M, Ahmadpanah M, Soltanian AR. Prevalence and factors associated with methamphetamine use among adult substance abusers. J Res Health Sci 2014; 14:221-226.
8. UNODC. India: Amphetaminetype stimulants now an emerging trend in the country. 2014; http://www.unodc.org/southasia//frontpage/2014/Jan/indiafirst- ever-study-looks-at-trends-in-amphetamine-type-stimulants-use.html. [Accessed on December 23, 2014], 2014.
9. Loffredo CA, Boulos DNK, Saleh DA, et al. Substance use by Egyptian youth: current patterns and potential avenues for prevention. Subst Use Misuse 2014; 0:; null.
10. Bramness JG, Reid MJ, Solvik KF, Vindenes V. Recent trends in the availability and use of amphetamine and methamphetamine in Norway. Forensic Sci Int 2015; 246:92-97.
11. Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Vol 1042009:1085-1099.
12. Mc Ketin R, Kozel N, Douglas J, et al. The rise of methamphetamine in Southeast and East Asia. Drug Alcohol Rev 2008; 27:220-228.
13. Greenfeld KT. The need for speed. Times Asian Edition ed 2001.
14. Pharma J. Constituents of Yaba (original article in Thai language). 2008.
15. Methamphetamine Pubchem Open Chemistry Database [Accessed on 17 November 2014].
16. ATS Information The GLobl Smart Program:UNDOC. [Accessed on 18 November 2014].
17. Schifano F, Corkery JM, Cuffolo G. Smokable ('ice', 'crystal meth') and non smokable amphetamine-type stimulants: Clinical pharmacological and epidemiological issues, with special reference to the UK. Annali dell'Istituto Superiore di Sanita 2007; 43:110-115.
18. Degenhardt L, Roxburgh A, Black E, et al. The epidemiology of methamphetamine use and harm in Australia. Drug Alcohol Rev 2008; 27:243-252.
19. Topp L, Degenhardt L, Kaye S, Darke S. The emergence of potent forms of methamphetamine in Sydney, Australia: a case study of the IDRS as a strategic early warning system. Drug Alcohol Rev 2002; 21:341-348.
20. Griffiths P, Mravcik V, Lopez D, Klempova D. Quite a lot of smoke but very limited fire - the use of methamphetamine in Europe. Drug Alcohol Rev 2008; 27:236.
21. Sanggil C, Sewoong H, Hyeyoung C, et al. Analysis of pharmaceutical impurities in the methamphetamine crystals seized for drug trafficking in Korea. Forensic Sci Int 2013; 227:48-51.
22. Zhang JX, Zhang da M, Han XG. Identification of impurities and statistical classification of methamphetamine hydrochloride drugs seized in China. Forensic Sci Int 2008; 182:13-19.
23. Thailand Cf Do ARi N. Physical characteristics and major constituents of Yaba. Regional Medical Center 10 -, Chiang Mai; 2005.
24. Chomchai C, Manaboriboon B. Stimulant methamphetamine and dextromethorphan use among Thai adolescents: implications for health of women and children. J Med Toxicol 2012; 8:291-294.
25. Methed up; The methamphetamine business. The Economist. Vol 402. London: The Economist Intelligence Unit; 2012:62.
26. Dargan PI, Wood DM. Recreational drug use in the Asia Pacific region: improvement in our understanding of the problem through the UNODC programmes. J Med Toxicol 2012; 8:295-299.
27. Ekici B, Ozbay S. Iranian methamphetamine and Turkey: an emerging transnational threat. Trend Organ Crime 2013; 16:286-305.
28. Gruenewald PJ, Ponicki WR, Remer LG, et al. Mapping the spread of methamphetamine abuse in California from 1995 to 2008. Am J Public Health 2013; 103:1262-1270.
29. Khan T. Cooking in Karachi: the world's most dangerous megacity is the next frontier in the global meth trade. Foreign Policy 2013; 76.
30. Cook CE, Jeffcoat AR, Sadler BM, et al. Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans. Drug Metab Dispos 1992; 20:856-862.
31. Cook CE, Jeffcoat AR, Hill JM, et al. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos 1993; 21:717-723.
32. Ganapathy V. Minireview: drugs of abuse and human placenta. Life Sci 2011; 88:926-930.
33. Bartu A, Dusci LJ, Ilett KF. Transfer of methylamphetamine and amphetamine into breast milk following recreational use of methylamphetamine. Br J Clin Pharmacol 2009; 67:455-459.
34. Sitte HH, Freissmuth M. Amphetamines, new psychoactive drugs and the monoamine transporter cycle. Trends Pharmacol Sci 2015; 36:41-50.
35. Ladhani NNN, Shah PS, Murphy KE. Prenatal amphetamine exposure and birth outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol 2011; 205:219e211-219e217.
36. DH J. Chapter 76: Amphetamines. In: Hoffman RSHM, Lewin NA, Nelson LS, Goldfrank LR, editors. Goldfrank's Toxicologic Emergencies, 10e. New York: NY: ; 2015. Gives a good overview of the pharmacology and toxicology of methamphetamine.
37. Watt MH, Meade CS, Kimani S, et al. The impact of methamphetamine ('tik') on a peri-urban community in Cape Town, South Africa. Int J Drug Policy 2014; 25:219-225.
38. Li L, Assanangkornchai S, Duo L, et al. Cross-border activities and association with current methamphetamine use among Chinese injection drug users (IDUs) in a China-Myanmar border region. Drug Alcohol Depend 2014; 138:48-53.
39. Liao M, Kang D, Tao X, et al. Dual epidemics of syphilis and methamphetamine use among drug users in Shandong Province of China. AIDS Care 2013; 25:1236-1244.
40. Couture M-C, Evans JL, Sothy NS, et al. Correlates of amphetamine-type stimulant use and associations with HIV-related risks among young women engaged in sex work in Phnom Penh, Cambodia. Drug Alcohol Depend 2012; 120:119-126.
41. Celentano DD, Sirirojn B, Sutcliffe CG, et al. Sexually transmitted infections and sexual and substance use correlates among young adults in Chiang Mai, Thailand. Sex Transm Dis 2008; 35:400-405.
42. Mc Ketin R, Ross J, Kelly E, et al. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug Alcohol Rev 2008; 27:277-285.
43. Jui H, Jii-Jun L, Wen-Ing T. Analysis of drug abuse data reported by medical institutions in Taiwan from 2002 to 2011. J Food Drug Anal 2014; 22:169-177.
44. Chung H. Drug abuse trends and epidemiological aspects of drug associated deaths in Korea. J Toxicol Sci 1998; 23 (Suppl 2):197-200.
45. Brecht ML, O'Brien A, von Mayrhauser C, Anglin MD. Methamphetamine use behaviors and gender differences. Addict Behav 2004; 29:89-106.
46. Zapata LB, Hillis SD, Marchbanks PA, et al. Methamphetamine use is independently associated with recent risky sexual behaviors and adolescent pregnancy. J Sch Health 2008; 78:641-648.
47. Committee opinion no 479: methamphetamine abuse in women of reproductive age. Obstet Gynecol 2011; 117:751-755.
48. Wouldes T, La Gasse L, Sheridan J, Lester B. Maternal methamphetamine use during pregnancy and child outcome: what do we know? N Z Med J 2004; 117:U1180.
49. Arria AM, Derauf C, La Gasse LL, et al. Methamphetamine and other substance use during pregnancy: preliminary estimates from the infant development, environment, and lifestyle (IDEAL) study. Matern Child Health J 2006; 10:293-302.
50. Della Grotta S, La Gasse L, Arria A, et al. Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) study. Matern Child Health J 2010; 14:519-527.
51. Oei JL, Kingsbury A, Dhawan A, et al. Amphetamines, the pregnant woman and her children: a review. 2012.
52. Good MM, Solt I, Acuna JG, et al. Methamphetamine use during pregnancy: maternal and neonatal implications. Obstet Gynecol 2010; 116 (2 Part 1):330-334; 310.1097/AOG.1090b1013e3181e67094.
53. Chomchai C, Na Manorom N, Watanarungsan P, et al. Methamphetamine abuse during pregnancy and its health impact on neonates born at Siriraj Hospital, Bangkok, Thailand. Southeast Asian J Trop Med Public Health 2004; 35:228-231.
54. Gorman MC, Orme KS, Nguyen NT, et al. Outcomes in pregnancies complicated by methamphetamine use. Am J Obstet Gynecol 2014; 211: 429e421-429e427.
55. Nguyen D, Smith LM, La Gasse LL, et al. Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study. The J Pediatr 2010; 157:337-339.
56. Xu JJ, Zhang C, Hu QH, et al. Recreational drug use and risks of HIV and sexually transmitted infections among Chinese men who have sex with men: mediation through multiple sexual partnerships. BMC Infect Dis 2014; 14:642. Establishes a strong connection between methamphetamine as a recreational drug-of-choice and the associated high-risk sexual behavior and HIV transmission.
57. Oldenburg CE, Jain S, Mayer KH, Mimiaga MJ. Postexposure prophylaxis use and recurrent exposure to HIV among men who have sex with men who use crystal methamphetamine. Drug Alcohol Depend 2015; 146: 75-80.
58. Drumright LD, Patterson TL, Strathdee SA. Club drugs as causal risk factors for hiv acquisition among men who have sex with men: a review. Subst Use Misuse 2006; 41:1551-1601.